These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 32323922)

  • 1. Inhibition of transcription by dactinomycin reveals a new characteristic of immunogenic cell stress.
    Humeau J; Sauvat A; Cerrato G; Xie W; Loos F; Iannantuoni F; Bezu L; Lévesque S; Paillet J; Pol J; Leduc M; Zitvogel L; de Thé H; Kepp O; Kroemer G
    EMBO Mol Med; 2020 May; 12(5):e11622. PubMed ID: 32323922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. eIF2α phosphorylation is pathognomonic for immunogenic cell death.
    Bezu L; Sauvat A; Humeau J; Gomes-da-Silva LC; Iribarren K; Forveille S; Garcia P; Zhao L; Liu P; Zitvogel L; Senovilla L; Kepp O; Kroemer G
    Cell Death Differ; 2018 Aug; 25(8):1375-1393. PubMed ID: 29358668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eliciting Immunogenic Cell Death via a Unitized Nanoinducer.
    Dai Z; Tang J; Gu Z; Wang Y; Yang Y; Yang Y; Yu C
    Nano Lett; 2020 Sep; 20(9):6246-6254. PubMed ID: 32786942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer metal drugs and immunogenic cell death.
    Terenzi A; Pirker C; Keppler BK; Berger W
    J Inorg Biochem; 2016 Dec; 165():71-79. PubMed ID: 27350082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural Compounds of Marine Origin as Inducers of Immunogenic Cell Death (ICD): Potential Role for Cancer Interception and Therapy.
    Sansone C; Bruno A; Piscitelli C; Baci D; Fontana A; Brunet C; Noonan DM; Albini A
    Cells; 2021 Jan; 10(2):. PubMed ID: 33504012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric Oxide Induces Immunogenic Cell Death and Potentiates Cancer Immunotherapy.
    Jiang W; Dong W; Li M; Guo Z; Wang Q; Liu Y; Bi Y; Zhou H; Wang Y
    ACS Nano; 2022 Mar; 16(3):3881-3894. PubMed ID: 35238549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenic cell death-inducing metal complexes: From the benchtop to the clinic.
    Sen S; Karoscik K; Maier E; Arambula JF
    Curr Opin Chem Biol; 2023 Apr; 73():102277. PubMed ID: 36867977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential Interferon β-Cisplatin Treatment Enhances the Surface Exposure of Calreticulin in Cancer Cells via an Interferon Regulatory Factor 1-Dependent Manner.
    Yang PM; Hsieh YY; Du JL; Yen SC; Hung CF
    Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32326356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent progress in stimuli-responsive nanosystems for inducing immunogenic cell death.
    Banstola A; Poudel K; Kim JO; Jeong JH; Yook S
    J Control Release; 2021 Sep; 337():505-520. PubMed ID: 34314800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-in-class ruthenium anticancer drug (KP1339/IT-139) induces an immunogenic cell death signature in colorectal spheroids in vitro.
    Wernitznig D; Kiakos K; Del Favero G; Harrer N; Machat H; Osswald A; Jakupec MA; Wernitznig A; Sommergruber W; Keppler BK
    Metallomics; 2019 Jun; 11(6):1044-1048. PubMed ID: 30942231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural modulators of the hallmarks of immunogenic cell death.
    Radogna F; Dicato M; Diederich M
    Biochem Pharmacol; 2019 Apr; 162():55-70. PubMed ID: 30615863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenic cell death in cancer therapy: Present and emerging inducers.
    Zhou J; Wang G; Chen Y; Wang H; Hua Y; Cai Z
    J Cell Mol Med; 2019 Aug; 23(8):4854-4865. PubMed ID: 31210425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunogenic cell death in hematological malignancies].
    Matsushita M
    Rinsho Ketsueki; 2021; 62(7):709-716. PubMed ID: 34349052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of immunogenic cell death and its relevance for cancer therapy.
    Fucikova J; Kepp O; Kasikova L; Petroni G; Yamazaki T; Liu P; Zhao L; Spisek R; Kroemer G; Galluzzi L
    Cell Death Dis; 2020 Nov; 11(11):1013. PubMed ID: 33243969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Massively Evoking Immunogenic Cell Death by Focused Mitochondrial Oxidative Stress using an AIE Luminogen with a Twisted Molecular Structure.
    Chen C; Ni X; Jia S; Liang Y; Wu X; Kong D; Ding D
    Adv Mater; 2019 Dec; 31(52):e1904914. PubMed ID: 31696981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PlatinER: A Highly Potent Anticancer Platinum(II) Complex that Induces Endoplasmic Reticulum Stress Driven Immunogenic Cell Death.
    Tham MJR; Babak MV; Ang WH
    Angew Chem Int Ed Engl; 2020 Oct; 59(43):19070-19078. PubMed ID: 32716112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imiquimod Exerts Antitumor Effects by Inducing Immunogenic Cell Death and Is Enhanced by the Glycolytic Inhibitor 2-Deoxyglucose.
    Huang SW; Wang ST; Chang SH; Chuang KC; Wang HY; Kao JK; Liang SM; Wu CY; Kao SH; Chen YJ; Shieh JJ
    J Invest Dermatol; 2020 Sep; 140(9):1771-1783.e6. PubMed ID: 32035924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metal-based anticancer agents as immunogenic cell death inducers: the past, present, and future.
    Sen S; Won M; Levine MS; Noh Y; Sedgwick AC; Kim JS; Sessler JL; Arambula JF
    Chem Soc Rev; 2022 Feb; 51(4):1212-1233. PubMed ID: 35099487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Target Profiling of an Iridium(III)-Based Immunogenic Cell Death Inducer Unveils the Engagement of Unfolded Protein Response Regulator BiP.
    Xiong X; Huang KB; Wang Y; Cao B; Luo Y; Chen H; Yang Y; Long Y; Liu M; Chan ASC; Liang H; Zou T
    J Am Chem Soc; 2022 Jun; 144(23):10407-10416. PubMed ID: 35658433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination Cancer Immunotherapy of Nanoparticle-Based Immunogenic Cell Death Inducers and Immune Checkpoint Inhibitors.
    Qi J; Jin F; Xu X; Du Y
    Int J Nanomedicine; 2021; 16():1435-1456. PubMed ID: 33654395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.